Search results for "Myocarditis"
Expert clinical decision pathway details diagnosis, management of myocarditis
The guidance from the American College of Cardiology includes a five-step care pathway for myocarditis, including strategies for diagnosis, risk stratification, and surveillance, and proposes four new stages of disease classification.
https://immattersacp.org/weekly/archives/2024/12/17/5.htm
17 Dec 2024
More clarity on myocarditis with mRNA COVID-19 vaccines
The classic presentation for COVID-19 vaccine-associated myocarditis is chest pain one to seven days after vaccination, with a median time of three days after vaccination, particularly after the second dose.
https://immattersacp.org/archives/2023/02/more-clarity-on-myocarditis-with-mrna-covid-19-vaccines.htm
1 Feb 2023
New COVID-19 vaccine authorized; reviews analyze myocarditis, drug treatments
The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting COVID-19 drug treatments.
https://immattersacp.org/weekly/archives/2022/07/19/4.htm
19 Jul 2022
Advice on writing an op-ed
Medical misinformation can kill, and it's everywhere, so one physician proposed countering it by writing medical op-eds.
https://immattersacp.org/archives/2024/06/advice-on-writing-an-op-ed.htm
1 Jun 2024
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021
Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare
A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.
https://immattersacp.org/weekly/archives/2021/10/05/1.htm
5 Oct 2021
COVID-19 pill study; new vaccine recommendation plus data on waning efficacy, low risk of postvaccine myocarditis; updates on experimental treatments
A peer-reviewed study showed molnupiravir reduced hospitalizations and deaths in high-risk patients, the CDC favored mRNA vaccines over J&J's, experts explained potential issues with waning efficacy data, and a study quantified the low risk of myocarditis after vaccination.
https://immattersacp.org/weekly/archives/2021/12/21/1.htm
21 Dec 2021
Watching weight for women
This month's issue addresses weight gain in women, celiac disease, and mRNA COVID-19 vaccines and myocarditis.
https://immattersacp.org/archives/2023/02/watching-weight-for-women.htm
1 Feb 2023
New recommendations for high-risk outpatients; data on omicron and boosters, breakthrough infections, myocarditis
The NIH updated its COVID-19 treatment guidelines for high-risk outpatients in response to the omicron variant, recommending the combination of ritonavir-nirmatrelvir above other options, and studies showed the effect of a booster dose. ACP practice points and new research looked at immunity conferred by infection or vaccination. Two studies quantified association of carditis with the mRNA vaccines.
https://immattersacp.org/weekly/archives/2022/01/25/1.htm
25 Jan 2022
BiPAP machines, masks recalled
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/11/bipap-machines-masks-recalled.htm
1 Nov 2022